This inventor holds 14 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc., Other. Active years: 2002-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
13 out of 1,562 
2 out of 278 
1 out of 834,570 Years Active: 2002-2025
Title: Karl-Heinz Heider: Pioneering Immunotherapies through Inventiveness
Introduction: Karl-Heinz Heider, a prolific inventor based in Stockerau, Austria, has made significant contributions to the field of immunotherapy with a total of 13 patents to his name.
Latest Patents: Among his latest patents are innovative CD33 binding agents, revolutionizing therapies for myeloid cell malignancies and myelodysplastic syndrome. Additionally, his work on anti-CD37 antibodies showcases his dedication to treating B cell malignancies and autoimmune diseases involving B cells.
Career Highlights: Heider has lent his expertise to renowned companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc., where he played a pivotal role in developing groundbreaking pharmaceutical solutions.
Collaborations: Collaborating with esteemed professionals like Elinborg Ostermann and Eric Borges, Heider has showcased his ability to work synergistically to drive innovation in the medical field.
Conclusion: Karl-Heinz Heider's relentless pursuit of advancing immunotherapies underscores his commitment to improving healthcare outcomes and solidifies his place as a trailblazer in the realm of medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile